Revivocell is delighted to have been awarded Future Innovation Fund from the Liverpool City Region for the development of a novel screening tool for COVID-19 virus.
With the current COVID-19 pandemic there remains great uncertainty about number of future infections and possible deaths. There is a need for more accurate and cost effective detection tools that can be widely used without highly specialised training and expensive equipment. The current established detection tools are expensive and require dedicated equipment, trained personnel and numerous reagents which are running low.
Revivocell will be collaborating with Daresbury Proteins to develop the new COVID-19 testing platform, which is rapid, easy to use, lower cost and highly accurate.
The new CELLBLOKS® platform is versatile and straightforward to use, enabling researchers to create their own unique experiments. CELLBLOKS® is unique because like no other plate platform allows you to study complex in-vivo like cell-cell interaction studies with ease. The interactive “plug and play” nature of the device makes it versatile allowing you to perform a wide range of cell-cell combination studies. Using CELLBLOKS® you can build complex models by simply putting together different cell growth Blocks in one platform that are designed to mimic both barrier organs and those in systematic circulation.
The platform is designed in standard SBS plate format that makes it compatible with standard readout equipment and minimizes any workflow disruption.
Three platform options available include:
The technology has number of applications including:
If you like to work with Revivocell on development projects and products where CELLBLOKS® technology could improve your research outcomes please contact us.
]]>